Listen "What's new in PAH in 2024"
Episode Synopsis
Dr. Melissa Wilson discusses new treatments in the field of pulmonary hypertension in 2024, focusing on Sotatercept and combination therapy with Opsynvi. Dr. Wilson emphasizes the importance of patient selection and individualized treatment plans. She also discusses the initiation and monitoring of these therapies, as well as potential side effects and patient adherence.
Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA.Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.comFollow us on:
Instagram @pulmapps
Twitter @pulmapp
Facebook @association of pulmonary advance practice providers.
Claim your 0.5 CME credits for listening to this episode here: https://forms.gle/42yHmF8UpemVhdDJA.Visit our website for more APP Pulmonary, Critical Care, and Sleep Medicine content and free CMEs www.pulmapp.comFollow us on:
Instagram @pulmapps
Twitter @pulmapp
Facebook @association of pulmonary advance practice providers.
More episodes of the podcast The APAPP Podcast
Developing an APP run COPD Clinic
30/11/2025
AI in Lung Cancer Screening
31/10/2025
ILD in Scleroderma
30/09/2025
Advancing ILD & PH-ILD Care
21/09/2025
COPD Symposium Review
21/09/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.